Ibuprom, Vaikams (Ibuprofen)

Ibuprofen blocks the activity of cyclo‑oxygenase enzymes (COX‑1 and COX‑2), which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it reduces inflammation, pain signaling, and fever, providing therapeutic relief across various conditions.

The appropriate dose of Ibuprom, Vaikams is determined by the prescribing healthcare professional based on the patient’s age, weight, condition being treated, and overall health status. The prescriber will set the exact dosage and duration for each individual case.

Ibuprofen is generally not recommended during the third trimester of pregnancy because it may affect fetal cardiovascular development. Use during early pregnancy or while breastfeeding should only be considered if the potential benefit outweighs the risk and after consulting a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ibuprom, Vaikams (ibuprofen) offers a balanced profile of analgesic, antipyretic and anti‑inflammatory activity, similar to other NSAIDs such as naproxen or diclofenac. Compared with some alternatives, ibuprofen has a relatively short half‑life, which may allow for flexible dosing but may also require more frequent administration for sustained effect.

Ibuprom, Vaikams should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Ibuprom, Vaikams is supplied as oral tablets and is taken by mouth with a full glass of water. It may be taken with or without food, although taking it with food can reduce the likelihood of gastrointestinal discomfort.

The most serious risks include severe gastrointestinal bleeding or ulceration, allergic reactions such as anaphylaxis, acute kidney injury, and increased cardiovascular events in high‑risk patients. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Ibuprom, Vaikams should be avoided in individuals with known hypersensitivity to ibuprofen or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, and in the third trimester of pregnancy. Patients with significant renal or hepatic impairment should also consult a healthcare professional before use.